Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
Condition(s):NeuroblastomaLast Updated:September 30, 2014Completed
Hide Studies Not Open or Pending
Condition(s):NeuroblastomaLast Updated:September 30, 2014Completed
Condition(s):Cervical Ripening; Labor, InducedLast Updated:June 25, 2012Completed
Condition(s):Diabetes, Type ILast Updated:October 16, 2014Completed
Condition(s):Multiple Sclerosis, Relapsing-RemittingLast Updated:March 21, 2017Completed
Condition(s):Hereditary Breast and Ovarian Cancer Syndrome; Osteoporosis; Ovarian CarcinomaLast Updated:March 24, 2020Completed
Condition(s):Metastatic Breast CancerLast Updated:November 3, 2016Completed
Condition(s):Leukemia, Myeloid, Chronic; Leukemia, Lymphocytic, Acute, L2Last Updated:February 8, 2010Completed
Condition(s):HIV; HIV-1; Human Immunodeficiency VirusLast Updated:July 29, 2008Completed
Condition(s):Pancreas CancerLast Updated:May 1, 2013Completed
Condition(s):Infections, Papillomavirus; Papillomavirus VaccinesLast Updated:January 2, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.